Hence, the development of ATOX1‐targeting drugs is crucial for treating neurological disorders.[20, 21] In addition, activated by copper, Atox1 acts as an innovative transcription factor that facilitates nuclear translocation, DNA binding, and transactivation, which in turn promotes cell proliferation.[22, 23]. The gene discussed is ATOX1; the disease is nervous system disorder.